<?xml version="1.0" encoding="UTF-8"?>
<p id="p1225">The Walter Reed Army Institute of Research also developed a tetravalent live-attenuated dengue vaccine based on serial passage of wild-type DENV in PDK cells. Among the selected passage levels, the seroconversion rates were 100%, 92%, 46%, and 58% for a single dose of DENV-1, -2, -3, and -4, respectively (
 <xref rid="bib168" ref-type="bibr">Kanesa-Thasan et al., 2003</xref>).
</p>
